<産業資料/調査レポートの題名> 2022年7月15日

網膜障害治療の世界市場:疾患徴候別(黄斑変性、糖尿病性網膜症、糖尿病黄斑浮腫、その他(網膜静脈閉塞など))、治療クラス別(抗VEGF剤、その他(抗炎症薬など))、投与形態別(ゲル、目薬、カプセル&錠剤、点眼薬、軟膏)、流通経路別(病院薬局、小売薬局、オンライン販売)


◆英文タイトル:Global Retinal Disorder Treatment Market Size study, by Disease Indication (Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, Others (Retinal Vein Occlusion, etc.)), by Therapeutic Class (Anti-VEGF Agents, Others (Anti-inflammatory Drugs, etc.)), by Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales) and Regional Forecasts 2019-2026

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Retinal Disorder Treatment Market, by Disease Indication, 2017-2026 (USD Billion)
1.2.2. Retinal Disorder Treatment Market, by Therapeutic Class, 2017-2026 (USD Billion)
1.2.3. Retinal Disorder Treatment Market, by Dosage Form, 2017-2026 (USD Billion)
1.2.4. Retinal Disorder Treatment Market, by Distribution Channel, 2017-2026 (USD Billion)
1.2.5. Retinal Disorder Treatment Market, by Region, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Retinal Disorder Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Retinal Disorder Treatment Market Dynamics
3.1. Retinal Disorder Treatment Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Retinal Disorder Treatment Market Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Retinal Disorder Treatment Market, by Disease Indication
5.1. Market Snapshot
5.2. Global Retinal Disorder Treatment Market by Disease Indication, Performance – Potential Analysis
5.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Disease Indication 2016-2026 (USD Billion)
5.4. Retinal Disorder Treatment Market, Sub Segment Analysis
5.4.1. Macular Degeneration
5.4.2. Diabetic Retinopathy
5.4.3. Diabetic Macular Edema
5.4.4. Others (Retinal Vein Occlusion, etc.)
Chapter 6. Global Retinal Disorder Treatment Market, by Therapeutic Class
6.1. Market Snapshot
6.2. Global Retinal Disorder Treatment Market by Therapeutic Class, Performance – Potential Analysis
6.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Therapeutic Class, 2016-2026 (USD Billion)
6.4. Retinal Disorder Treatment Market, Sub Segment Analysis
6.4.1. Anti-VEGF Agents
6.4.2. Others (Anti-inflammatory Drugs, etc.)
Chapter 7. Global Retinal Disorder Treatment Market, by Dosage Form
7.1. Market Snapshot
7.2. Global Retinal Disorder Treatment Market by Dosage Form, Performance – Potential Analysis
7.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Dosage Form, 2016-2026 (USD Billion)
7.4. Retinal Disorder Treatment Market, Sub Segment Analysis
7.4.1. Gels
7.4.2. Eye Solutions
7.4.3. Capsules & Tablets
7.4.4. Eye Drops
7.4.5. Ointments
Chapter 8. Global Retinal Disorder Treatment Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Retinal Disorder Treatment Market by Distribution Channel, Performance – Potential Analysis
8.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Distribution Channel, 2016-2026 (USD Billion)
8.4. Retinal Disorder Treatment Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Sales
Chapter 9. Global Retinal Disorder Treatment Market, Regional Analysis
9.1. Retinal Disorder Treatment Market, Regional Market Snapshot
9.2. North America Retinal Disorder Treatment Market
9.2.1. U.S. Retinal Disorder Treatment Market
9.2.1.1. Disease Indication breakdown estimates & forecasts, 2016-2026
9.2.1.2. Therapeutic Class breakdown estimates & forecasts, 2016-2026
9.2.1.3. Dosage Form breakdown estimates & forecasts, 2016-2026
9.2.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026
9.2.2. Canada Retinal Disorder Treatment Market
9.3. Europe Retinal Disorder Treatment Market Snapshot
9.3.1. U.K. Retinal Disorder Treatment Market
9.3.2. Germany Retinal Disorder Treatment Market
9.3.3. Rest of Europe Retinal Disorder Treatment Market
9.4. Asia-Pacific Retinal Disorder Treatment Market Snapshot
9.4.1. China Retinal Disorder Treatment Market
9.4.2. India Retinal Disorder Treatment Market
9.4.3. Japan Retinal Disorder Treatment Market
9.4.4. Rest of Asia Pacific Retinal Disorder Treatment Market
9.5. Latin America Retinal Disorder Treatment Market Snapshot
9.5.1. Brazil Retinal Disorder Treatment Market
9.5.2. Mexico Retinal Disorder Treatment Market
9.6. Rest of The World Retinal Disorder Treatment Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Santen Pharmaceutical Co., Ltd.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject To Data Availability)
10.2.1.4. Sensor Type Summary
10.2.1.5. Recent Developments
10.2.2. Regeneron Pharmaceuticals, Inc.
10.2.3. F. Hoffmann-La Roche Ltd.
10.2.4. Pfizer, Inc.
10.2.5. Allergan plc
10.2.6. Shire (Takeda Pharmaceutical Company Limited)
10.2.7. Bayer AG
10.2.8. Graybug Vision, Inc.
10.2.9. Novartis AG
10.2.10. Acucela Inc. (Kubota Pharmaceutical Holdings Co., Ltd.)
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark